chr13-110480066-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001846.4(COL4A2):​c.2588-154C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.121 in 152,256 control chromosomes in the GnomAD database, including 1,221 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 1221 hom., cov: 34)

Consequence

COL4A2
NM_001846.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -2.72

Publications

1 publications found
Variant links:
Genes affected
COL4A2 (HGNC:2203): (collagen type IV alpha 2 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. The C-terminal portion of the protein, known as canstatin, is an inhibitor of angiogenesis and tumor growth. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jul 2008]
COL4A2 Gene-Disease associations (from GenCC):
  • porencephaly 2
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • COL4A1 or COL4A2-related cerebral small vessel disease
    Inheritance: AD Classification: MODERATE Submitted by: Illumina
  • familial porencephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BP6
Variant 13-110480066-C-T is Benign according to our data. Variant chr13-110480066-C-T is described in ClinVar as Benign. ClinVar VariationId is 1293754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.142 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A2NM_001846.4 linkc.2588-154C>T intron_variant Intron 30 of 47 ENST00000360467.7 NP_001837.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A2ENST00000360467.7 linkc.2588-154C>T intron_variant Intron 30 of 47 5 NM_001846.4 ENSP00000353654.5

Frequencies

GnomAD3 genomes
AF:
0.121
AC:
18440
AN:
152138
Hom.:
1221
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.108
Gnomad AMI
AF:
0.185
Gnomad AMR
AF:
0.107
Gnomad ASJ
AF:
0.148
Gnomad EAS
AF:
0.00212
Gnomad SAS
AF:
0.0314
Gnomad FIN
AF:
0.126
Gnomad MID
AF:
0.207
Gnomad NFE
AF:
0.144
Gnomad OTH
AF:
0.128
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.121
AC:
18450
AN:
152256
Hom.:
1221
Cov.:
34
AF XY:
0.118
AC XY:
8793
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.108
AC:
4487
AN:
41550
American (AMR)
AF:
0.107
AC:
1632
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.148
AC:
512
AN:
3470
East Asian (EAS)
AF:
0.00212
AC:
11
AN:
5184
South Asian (SAS)
AF:
0.0319
AC:
154
AN:
4830
European-Finnish (FIN)
AF:
0.126
AC:
1340
AN:
10606
Middle Eastern (MID)
AF:
0.202
AC:
59
AN:
292
European-Non Finnish (NFE)
AF:
0.144
AC:
9813
AN:
68000
Other (OTH)
AF:
0.130
AC:
274
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
830
1660
2489
3319
4149
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
194
388
582
776
970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.132
Hom.:
178
Bravo
AF:
0.122
Asia WGS
AF:
0.0480
AC:
167
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.16
DANN
Benign
0.54
PhyloP100
-2.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72657977; hg19: chr13-111132413; API